PTN Earnings Prediction
The chart below shows how PTN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PTN sees a +13.27% change in stock price 10 days leading up to the earnings, and a -6.12% change 10 days following the report. On the earnings day itself, the stock moves by -3.93%. This data can give you a slight idea of what to expect for the next quarter's release.
PTN Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
0.00
-100.00%
-100.00%
Gross Margin
--
--
--
Operating Margin
--
--
--
Net Margin
--
--
--
EPS
-0.39
-18.75%
-20.41%
No Data Available
PTN Earnings Analysis
Palatin Technologies, Inc. Corporation (PTN.A) Earnings Conference Call
Positive
Sales and Revenue Overview: For the first quarter ended September 30, 2023, gross product sales were $4.6 million and net product revenue was $2.1 million.
Operating Expense Reduction: Total operating expenses were $7.8 million for the first quarter ended September 30, 2024, compared to $8.2 million for the comparable quarter last year, indicating effective cost management.
Operational Cash Usage: Palatin's net cash used in operations for the quarter ended September 30, 2024, was $7 million compared to a net cash used in operations of approximately $5.9 million for the same period of 2023, reflecting improved operational efficiency.
Cash Position Analysis: As of September 30, 2024, Palatin's cash and cash equivalents were $2.4 million compared to cash and cash equivalents of $9.5 million as of June 30, 2024, indicating a strong liquidity position.
Strategic Options Evaluation: Palatin has retained an investment bank to conduct, explore and evaluate strategic options for its non-obesity programs, demonstrating proactive corporate actions to enhance shareholder value.
Negative
No Product Sales Recorded: Palatin did not record any product sales to pharmacy distributors for the first quarter ended September 30, 2024.
Revenue Decline Analysis: Gross product sales were $4.6 million and net product revenue was $2.1 million for the first quarter ended September 30, 2023, indicating a decline in revenue.
Operating Expenses Decrease: Total operating expenses were $7.8 million for the first quarter ended September 30, 2024, compared to $8.2 million for the comparable quarter last year, showing a decrease but still high expenses.
Increased Cash Burn: Palatin's net cash used in operations for the quarter ended September 30, 2024, was $7 million compared to a net cash used in operations of approximately $5.9 million for the same period of 2023, indicating increased cash burn.
Quarterly Net Loss Increase: Palatin's net loss for the quarter ended September 30, 2024, was $7.8 million, compared to a net loss of $5.2 million for the same period in 2023, reflecting worsening financial performance.
PTN FAQs
How does PTN typically perform around its earnings report dates?
Is Palatin Technologies, Inc. (PTN) Q1 2025 Earnings Conference Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
PTN Earning Call Sentiment
Palatin Technologies, Inc. (PTN) Q1 2025 Earnings Conference Call Transcript
1.0x
00:00
00:00
PTN.A
0%Positive
The earnings call summary indicates significant challenges: liquidity concerns with cash dropping from $9.5M to $2.4M, no product sales in Q1 2025, and increased net loss. Despite a deferred payment and potential partnerships, the focus on MCR-4 obesity limits diversification and increases risk. Q&A insights reveal interest but lack concrete partnership details, adding uncertainty. Overall, the negative financials and strategic risks outweigh the potential positives, leading to a negative sentiment prediction.
